How MemoHoney is meant to work: from citrulline to cerebral blood flow

Arginine is the substrate. Nitric oxide synthase takes arginine and oxygen and produces nitric oxide and citrulline. So the obvious way to make more nitric oxide is to swallow more arginine, and the obvious way is the one that works least well.

Oral arginine is heavily metabolised in the gut wall and the liver before it reaches the circulation. Citrulline is not: it passes through, and the kidney converts it back to arginine. the citrulline pharmacokinetic study demonstrated this directly, showing oral L-citrulline raising plasma arginine dose-dependently, with 3 grams twice a day lifting even the trough concentration.

That is why a label that already lists arginine twice also lists citrulline twice. It is not padding. It is the one design decision on this bottle that the literature straightforwardly supports.

Nitric oxide diffuses into vascular smooth muscle, raises cyclic GMP and relaxes the vessel wall. Wider vessels at the same pumping pressure means lower resistance and more flow, which is why this pathway is a blood-pressure pathway before it is anything else.

The human evidence is consistent at the right dose. the 2026 arginine blood pressure meta-analysis found 24-hour systolic pressure about 4.2 mmHg lower on oral arginine across five trials in 202 people. the citrulline blood pressure review found citrulline and watermelon intake lowering blood pressure in middle-aged and older adults.

There is one caution inside that story. the flow-mediated dilation study gave healthy young men 6 or 12 grams of citrulline malate acutely and found neither dose improved flow-mediated dilation, while both raised asymmetric and symmetric dimethylarginine, the endogenous inhibitors of the same enzyme the formula is trying to feed. More substrate is not automatically more product.

Niacin and beta-alanine do not belong to the nitric oxide story, and they get there by different routes.

Niacin is a genuine cognitive nutrient at dietary scale. It becomes NAD and NADP, severe deficiency causes the dementia of pellagra, and the Chicago dietary niacin cohort found higher dietary intake tracking lower Alzheimer's risk in 3,718 people. What that cannot establish is a benefit from adding more to an adequate diet, which is the situation most buyers of this bottle are in. The nicotinamide riboside trials are the closest anyone has come to testing the NAD idea directly: the 2024 nicotinamide riboside trial and the phase-II nicotinamide riboside pilot both ran it in older adults with mild cognitive impairment, and neither produced the clear cognitive win the theory predicts.

Beta-alanine has no route in. It raises muscle carnosine and buffers acid during hard effort. On a memory label it is doing the work of a familiar-sounding name rather than the work of an active ingredient, and this desk would rather write that down than invent a mechanism for it.